SCHEMBL12439430

SCHEMBL12439430

CCN(CC)CCNc1cc(N)nc(NCc2cc(C(C)C)no2)n1

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 20/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12439431 0.94 IGF1R (0.68) IGF1R
SCHEMBL12439394 0.81 IGF1R (0.57) IGF1R
SCHEMBL4457289 0.81 IGF1R (1.00) IGF1R
SCHEMBL3931935 0.77 IGF1R (1.00) IGF1R
SCHEMBL12439820 0.77 IGF1R (0.58) IGF1R
SCHEMBL4459986 0.75 IGF1R (1.00) IGF1R
SCHEMBL4011707 0.72 IGF1R (1.00) IGF1R
SCHEMBL15580740 0.71 IGF1R (0.40) IGF1R
SCHEMBL14311612 0.71 IGF1R (0.59) IGF1R
SCHEMBL1791561 0.70 IGF1R (0.67) IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1841760-B1 PYRIMIDINE DERIVATIVES AS KINASE MODULATORS AND METHOD OF USE EXELIXIS INC (US) 2011-08-10 EP disclosed
WO-2008005538-A2 METHODS OF USING IGF1R AND ABL KINASE MODULATORS EXELIXIS, INC. (US) 2008-01-10 WO disclosed